Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Phreesia, Inc. PHR
$29.33
-$0.18 (-0.63%)
На 18:01, 12 мая 2023
+63.65%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
1583576400.00000000
-
week52high
40.00
-
week52low
13.19
-
Revenue
280910000
-
P/E TTM
-9
-
Beta
0.61794800
-
EPS
-3.44000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 мая 2023 г. в 20:00
Описание компании
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Piper Sandler | Overweight | Overweight | 14 июн 2022 г. |
RBC Capital | Sector Perform | Sector Perform | 06 июн 2022 г. |
Raymond James | Outperform | Outperform | 06 июн 2022 г. |
SVB Leerink | Market Perform | Market Perform | 03 июн 2022 г. |
JMP Securities | Market Outperform | Market Outperform | 03 июн 2022 г. |
Keybanc | Overweight | 16 сент 2022 г. | |
RBC Capital | Sector Perform | Sector Perform | 08 сент 2022 г. |
Guggenheim | Buy | Buy | 08 сент 2022 г. |
Canaccord Genuity | Buy | Buy | 08 сент 2022 г. |
DA Davidson | Neutral | 13 окт 2022 г. | |
DA Davidson | Neutral | 12 окт 2022 г. | |
SVB Leerink | Outperform | Outperform | 05 янв 2023 г. |
Needham | Buy | Buy | 04 янв 2023 г. |
Citigroup | Buy | Neutral | 13 дек 2022 г. |
Raymond James | Outperform | Outperform | 12 дек 2022 г. |
SVB Leerink | Outperform | Market Perform | 09 дек 2022 г. |
Keybanc | Overweight | Overweight | 02 февр 2023 г. |
Piper Sandler | Overweight | Overweight | 25 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
CAHILL EDWARD L | A | 37798 | 266 | 31 янв 2023 г. |
Goldstein Lainie | A | 23380 | 266 | 31 янв 2023 г. |
Munson Gillian | A | 22554 | 266 | 31 янв 2023 г. |
Davidoff Michael J. | D | 105484 | 3265 | 31 янв 2023 г. |
Davidoff Michael J. | D | 0 | 712 | 30 янв 2023 г. |
Davidoff Michael J. | D | 108749 | 16262 | 30 янв 2023 г. |
Davidoff Michael J. | D | 125011 | 12293 | 30 янв 2023 г. |
Davidoff Michael J. | A | 137304 | 712 | 30 янв 2023 г. |
Davidoff Michael J. | A | 136592 | 11378 | 30 янв 2023 г. |
Hoffman Allison C | D | 129507 | 649 | 18 янв 2023 г. |
Новостная лента
Phreesia, Inc. (PHR) Q4 2023 Earnings Call Transcript
Seeking Alpha
22 мар 2023 г. в 23:09
Phreesia, Inc. (PHR) Q4 2023 Earnings Conference Call March 22, 2023 5:00 PM ET Corporate Participants Balaji Gandhi - Senior Vice President, Investor Relations Chaim Indig - Chief Executive Officer Conference Call Participants Anne Samuel - JPMorgan Jared Haase - William Blair Jessica Tassan - Piper Sandler Joe Vruwink - Baird Glen Santangelo - Jefferies Sean Dodge - RBC Capital Markets Daniel Grosslight - Citi Richard Close - Canaccord Genuity John Ransom - Raymond James Scott Schoenhaus - KeyBanc Joe Goodwin - JMP Securities Ryan MacDonald - Needham Jack Wallace - Guggenheim Robert Simmons - D.A. Davidson Operator Good evening, ladies and gentlemen, and welcome to the Phreesia Fiscal Fourth Quarter 2023 Earnings Conference Call.
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
22 мар 2023 г. в 18:19
Phreesia (PHR) delivered earnings and revenue surprises of 7.69% and 2.56%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
What Makes Phreesia (PHR) a New Buy Stock
Zacks Investment Research
14 февр 2023 г. в 13:33
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Phreesia (PHR) Soars 6.1%: Is Further Upside Left in the Stock?
Zacks Investment Research
03 февр 2023 г. в 09:47
Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Phreesia - Healthcare Ecosystem At An Attractive Valuation
Seeking Alpha
13 дек 2022 г. в 18:32
Founders-led PHR has been adding clinics and patients to its ecosystem. The newly added clinics are smaller in scale, signaling the end of rapid market penetration.